NCT00294996_1A | R Documentation |
Kaplan-Meier digitized data from NCT00294996, figure 1A (PMID 24401928). A reported sample size of 181 for a primary endpoint of PFS in breast cancer.
NCT00294996_1A
A data frame of 363 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (mpt, pt) | |
Baselga J, Manikhas A, Cortés J, et al. Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer. Ann Oncol 2014; 25: 592–8.
summary(NCT00294996_1A)
kmplot(NCT00294996_1A)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.